Wikidata

(Q42595230)

English

4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis

scientific article published on November 1994

In more languages

Statements

title
4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017
author name string
Polman CH
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017
Bertelsmann FW
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017
de Waal R
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017
van Diemen HA
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017
Uitdehaag BM
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017
van Loenen AC
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017
Koetsier JC
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017
publication date
1 November 1994
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017
page(s)
1136-1139
1 reference
stated in
Europe PubMed Central
PubMed ID
7980110
retrieved
3 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42595230&oldid=2111968379"